Inpegsomatropin

怡培生长激素

Report date: 2026/04/28 20:00:22

Base Information

Drug NameInpegsomatropin
Drug Alias NameYPEG-GHY 型聚乙二醇重组人生长激素Y 型 PEG 化重组人生长激素YPEG-rhGHYPEG-somatropin +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[4] 
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaGrowth hormone deficiency
Original Approved Country/TerritoryMainland China
Original Approved Date2025/05/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXiamen Amoytop Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Amoytop Biotech Co LtdXiamen Bosai Gene Transcription Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A